Meet with... National Cancer Institute

Add this event to your calendar:
30/09/2014 15:00 30/09/2014 17:00 America/New_York Meet with... National Cancer Institute Mount Sinai Health System , Icahn Building, 1st Floor, Goldwurm Auditorium , New York , NY 10029 Johnson & Johnson Innovation, JLABS false DD/MM/YYYY
September
30
Event

Meet with... National Cancer Institute

Mount Sinai Health System , Icahn Building, 1st Floor, Goldwurm Auditorium , New York , NY 10029

September 30, 2014 from 15:00 PM to 17:00 PM (EDT)

$10 - $35


JANSSEN LABS BOSTON / NEW YORK EVENT NCI: New SBIR Opportunities for Early-Stage and Venture-Backed Companies

Program Director Amir Rahbar, Ph.D., MBA, will discuss new non-dilutive contract funding opportunities available for early stage companies to develop the next generation of cancer technologies and therapeutics.

During this session, NCI leader Amir Rahbar will provide an update on recently released funding opportunities available to small businesses as well as tips on strengthening your application. The SBIR program helps fill the gap in the availability of early stage funding created when investors and strategic partners move towards clinical-stage investments. SBIR funds serve as a key bridge between initial angel funding and more significant angel capital, venture capital, or strategic partnerships.

Additionally, the presentation will provide valuable information on NCI's other initiatives including the NCI SBIR Bridge Award, the NCI SBIR Investor Forum, and I-Corps™ at NIH. Get all of your questions answered during the Q&A session following the presentation.

Agenda:
1:00 PM | Registration & Networking
1:30 PM | Amir Rahbar: "Overview of NCI SBIR and tips for applying"
2:15 PM | Q&A Session
2:30 PM | Networking Reception
3:00 PM | One-on-one Meetings with Amir Rahbar*
5:00 PM | Program Close

*Companies must apply ahead of time and be approved for a one-on-one meeting. One-on-ones will be accepted on a first come, first served basis, with eight total spots. All companies accepted for a one-on-one meeting will be notified of acceptance and scheduled meeting time via email. If you are interested in a one-on-one meeting with Amir, please email Brittany Connors at [email protected]. Please include an executive summary.

National Cancer Institute Participating Representative:
Amir Rahbar, Ph.D., MBA | Program Director, SBIR Development Center, National Cancer Institute read bio»

About the National Cancer Institute:
The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that compose the Department of Health and Human Services (HHS). The NCI, established under the National Cancer Institute Act of 1937, is the Federal Government's principal agency for cancer research and training. The National Cancer Act of 1971 broadened the scope and responsibilities of the NCI and created the National Cancer Program. Over the years, legislative amendments have maintained the NCI authorities and responsibilities and added new information dissemination mandates as well as a requirement to assess the incorporation of state-of-the-art cancer treatments into clinical practice. The National Cancer Institute coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.

Fees:
Presentation and Q&A
$15 | General Public
$5 | Student/Academic
$20 | On-site
Includes a presentation, Q&A, and refreshments. All attendees must pay this fee, regardless of one-on-one meeting status. Registration to attend the presentation and Q&A will remain open until September 29 (or full).

One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Companies must apply ahead of time and be approved for a one-on-one meeting. One-on-ones will be accepted on a first come, first served basis, with eight total spots. All companies accepted for a one-on-one meeting will be notified of acceptance and scheduled meeting time via email. If you are interested in a one-on-one meeting with Amir, please email Brittany Connors at [email protected]. Please include an executive summary. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved.

Location:
Mt. Sinai Health System Mount Sinai Health System
Icahn Building, 1st Floor
Goldwurm Auditorium
1425 Madison Avenue
New York, NY 10029

Co-hosted by Mount Sinai Innovation Partners
Mount Sinai Innovation Partners (MSIP) facilitates the real-world application and commercialization of Mount Sinai discoveries and the development of research partnerships with industry. For more on MSIP, please visit www.ip.mountsinai.org.

National Cancer Institute Representative's Biography:
Amir Rahbar Amir Rahbar, Ph.D., MBA | Program Director, SBIR Development Center, National Cancer Institute
Dr. Rahbar is a Program Director in the Small Business Innovation Research (SBIR) Development Center at the National Cancer Institute. His management portfolio includes both grant and contract awards to support the pre-clinical development of novel oncology In-Vitro Diagnostics, Biologics, Therapeutics and Proteomics related projects. From 2009 to 2011, Dr. Rahbar served as a Program Manager for the Clinical Proteomics Technologies for Cancer initiative, a program in the NCI Office of Technology and Industrial Relations. In this role, he served as a technical resource and oversaw the development and assessment of proteomic technology platforms for cancer research. Prior to coming to NIH in 2009, Dr. Rahbar was a National Research Council Fellow at the US Naval Research Laboratory's Center for Bio/Molecular Science and Engineering where he was the lead on all proteomics related projects. After completing his fellowship in 2007 he stayed on to lead the proteomics segment of the Naval Research Lab's Systems Biology Group. After leaving the Naval Research Laboratory, Dr. Rahbar served as the Senior Science Market Analyst at BioInformatics, LLC, a life science market research and consulting firm. Dr. Rahbar received a B.S. and Ph.D. in Biochemistry from the University of Maryland, College Park, and an M.B.A. from American University's Kogod School of Business.



About the Meet with... Series:
The purpose of the Meet with Series events sponsored by Janssen Labs is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, MedImmune Ventures, NCI, Mercury Fund, Correlation Ventures, Breakout Labs, New Enterprise Associates, and Thomas McNerney & Partners.


Johnson & Johnson Innovation, JLABS

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS. About Johnson & Johnson Innovation Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation - JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit www.jnjinnovation.com or follow @JNJInnovation.

Event contact


Related content